| |
| |
|
| Insider
Information: |
Henderson Lori M |
| Relationship: |
General Counsel and Se... |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
62,896 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
62,896 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Albany Molecular Research Inc |
AMRI |
SVP, Secretary & Gen C... |
2017-03-02 |
61,995 |
|
0 |
Premium* |
|
|
Moderna, Inc. |
MRNA |
General Counsel and Se... |
2021-05-27 |
901 |
2020-05-20 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
102 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MRNA |
Moderna, Inc. |
General Counsel and Secretary |
• • – |
2021-03-25 |
4 |
AS |
$126.88 |
$837,408 |
D/D |
(6,600) |
901 |
0 |
- |
|
| MRNA |
Moderna, Inc. |
General Counsel and Secretary |
• • – |
2021-03-30 |
4 |
AS |
$123.30 |
$813,780 |
D/D |
(6,600) |
901 |
0 |
- |
|
| MRNA |
Moderna, Inc. |
General Counsel and Secretary |
• • – |
2021-04-01 |
4 |
AS |
$132.51 |
$874,566 |
D/D |
(6,600) |
901 |
0 |
- |
|
| MRNA |
Moderna, Inc. |
General Counsel and Secretary |
• • – |
2021-04-06 |
4 |
AS |
$130.01 |
$858,066 |
D/D |
(6,600) |
901 |
0 |
- |
|
| MRNA |
Moderna, Inc. |
General Counsel and Secretary |
• • – |
2021-04-08 |
4 |
AS |
$132.85 |
$876,810 |
D/D |
(6,600) |
901 |
0 |
- |
|
| MRNA |
Moderna, Inc. |
General Counsel and Secretary |
• • – |
2021-04-13 |
4 |
AS |
$146.62 |
$967,692 |
D/D |
(6,600) |
901 |
0 |
- |
|
| MRNA |
Moderna, Inc. |
General Counsel and Secretary |
• • – |
2021-04-15 |
4 |
AS |
$158.76 |
$1,047,816 |
D/D |
(6,600) |
901 |
0 |
- |
|
| MRNA |
Moderna, Inc. |
General Counsel and Secretary |
• • – |
2021-04-20 |
4 |
AS |
$160.32 |
$1,058,112 |
D/D |
(6,600) |
901 |
0 |
- |
|
| MRNA |
Moderna, Inc. |
General Counsel and Secretary |
• • – |
2021-04-22 |
4 |
AS |
$168.26 |
$1,110,516 |
D/D |
(6,600) |
901 |
0 |
- |
|
| MRNA |
Moderna, Inc. |
General Counsel and Secretary |
• • – |
2021-04-27 |
4 |
AS |
$178.29 |
$1,176,714 |
D/D |
(6,600) |
901 |
0 |
- |
|
| MRNA |
Moderna, Inc. |
General Counsel and Secretary |
• • – |
2021-04-29 |
4 |
AS |
$182.49 |
$1,204,434 |
D/D |
(6,600) |
901 |
0 |
- |
|
| MRNA |
Moderna, Inc. |
General Counsel and Secretary |
• • – |
2021-05-04 |
4 |
AS |
$185.25 |
$1,222,650 |
D/D |
(6,600) |
901 |
0 |
- |
|
| MRNA |
Moderna, Inc. |
General Counsel and Secretary |
• • – |
2021-05-06 |
4 |
AS |
$147.82 |
$975,612 |
D/D |
(6,600) |
901 |
0 |
- |
|
| MRNA |
Moderna, Inc. |
General Counsel and Secretary |
• • – |
2021-05-11 |
4 |
AS |
$151.31 |
$998,646 |
D/D |
(6,600) |
901 |
0 |
- |
|
| MRNA |
Moderna, Inc. |
General Counsel and Secretary |
• • – |
2021-05-13 |
4 |
AS |
$152.60 |
$1,007,160 |
D/D |
(6,600) |
901 |
0 |
- |
|
| MRNA |
Moderna, Inc. |
General Counsel and Secretary |
• • – |
2021-05-18 |
4 |
AS |
$160.16 |
$1,057,056 |
D/D |
(6,600) |
901 |
0 |
- |
|
| MRNA |
Moderna, Inc. |
General Counsel and Secretary |
• • – |
2021-05-20 |
4 |
AS |
$159.92 |
$1,055,472 |
D/D |
(6,600) |
901 |
0 |
- |
|
| MRNA |
Moderna, Inc. |
General Counsel and Secretary |
• • – |
2021-05-25 |
4 |
AS |
$166.58 |
$1,099,428 |
D/D |
(6,600) |
901 |
0 |
- |
|
| MRNA |
Moderna, Inc. |
General Counsel and Secretary |
• • – |
2021-05-27 |
4 |
AS |
$174.20 |
$1,149,720 |
D/D |
(6,600) |
901 |
0 |
- |
|
| AMRI |
Albany Molecular Research... |
VP, general counsel |
• – – |
2011-12-07 |
4 |
B |
$2.47 |
$14,573 |
D/D |
5,900 |
27,566 |
2.74 |
- |
|
| AMRI |
Albany Molecular Research... |
VP, general counsel |
• – – |
2012-06-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,458) |
37,774 |
0 |
- |
|
| AMRI |
Albany Molecular Research... |
VP, general counsel |
• – – |
2013-06-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(477) |
47,505 |
0 |
- |
|
| AMRI |
Albany Molecular Research... |
VP, general counsel |
• – – |
2013-06-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,458) |
47,982 |
0 |
- |
|
| AMRI |
Albany Molecular Research... |
VP, Secretary & Gen. Counsel |
• – – |
2014-01-31 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,106) |
46,399 |
0 |
- |
|
| AMRI |
Albany Molecular Research... |
VP, Secretary & Gen. Counsel |
• – – |
2014-02-04 |
4 |
D |
$0.00 |
$0 |
D/D |
(948) |
45,451 |
0 |
- |
|
102 Records found
|
|
Page 2 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
